Treatment with the C5a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model.

BMC Cardiovasc Disord · 2010 · PMC2955599 · PMID 20875134

Europe PMC DOI

hedged sentence

0.1600

closest p · 3.2× alpha

0.1600

boldest claim

The sentences

did not reach statistical significancep = 0.16not close (p > 0.1)

Infarct size unadjusted for differences in area at risk was also reduced in the ADC-1004 group, although it did not reach statistical significance (ADC-1004: 23.0 ± 3.0 vs control: 27.1 ± 1.4%LVM, p = 0.16) (Figure 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.